EnerSpar Corp. (TSE:NRX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NurExone Biologic Inc. has announced a significant stride in regenerative medicine by partnering with a German GMP manufacturer for the production of their ExoPTEN nanodrug’s active siRNA element. This collaboration is set to meet the high-quality standards necessary for clinical trials and potential commercialization. The new GMP-manufactured siRNA has demonstrated comparable effectiveness in reducing PTEN expression, crucial for nerve regeneration therapies.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.
